Your browser doesn't support javascript.
loading
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.
Kebir, Sied; Schaub, Christina; Junold, Nina; Hattingen, Elke; Schäfer, Niklas; Steinbach, Joachim P; Weyerbrock, Astrid; Hau, Peter; Goldbrunner, Roland; Galldiks, Norbert; Weller, Johannes; Mack, Frederic; Tzaridis, Theophilos; Bähr, Oliver; Seidel, Clemens; Schlegel, Uwe; Schmidt-Graf, Friederike; Rohde, Veit; Borchers, Christian; Tabatabai, Ghazaleh; Hänel, Mathias; Sabel, Michael; Gerlach, Rüdiger; Krex, Dietmar; Belka, Claus; Vatter, Hartmut; Proescholdt, Martin; Glas, Martin; Herrlinger, Ulrich.
Afiliação
  • Kebir S; Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany. Sied.Kebir@uk-essen.de.
  • Schaub C; West German Cancer Center (WTZ), University Hospital Essen and German Cancer Consortium, Partner Site University Hospital Essen, University Duisburg-Essen, Essen, Germany. Sied.Kebir@uk-essen.de.
  • Junold N; Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany. Sied.Kebir@uk-essen.de.
  • Hattingen E; Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany.
  • Schäfer N; Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany.
  • Steinbach JP; Institute of Neuroradiology, University of Frankfurt, Frankfurt, Germany.
  • Weyerbrock A; Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany.
  • Hau P; Dr. Senckenberg Institute of Neurooncology, University of Frankfurt, Frankfurt, Germany.
  • Goldbrunner R; Department of Neurosurgery, University of Freiburg, Freiburg, Germany.
  • Galldiks N; Department of Neurology and Wilhelm Sander Neurooncology Unit, University of Regensburg, Regensburg, Germany.
  • Weller J; Center for Neurosurgery, University of Cologne, Cologne, Germany.
  • Mack F; Department of Neurology, University of Cologne, Cologne, Germany.
  • Tzaridis T; Institute of Neuroscience and Medicine (INM-3), Research Center Juelich, Juelich, Germany.
  • Bähr O; Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany.
  • Seidel C; Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany.
  • Schlegel U; Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany.
  • Schmidt-Graf F; Dr. Senckenberg Institute of Neurooncology, University of Frankfurt, Frankfurt, Germany.
  • Rohde V; Department of Radiation Oncology, University of Leipzig, Leipzig, Germany.
  • Borchers C; Department of Neurology, Knappschaftskrankenhaus Klinikum Der Ruhr-Universität Bochum, Bochum, Germany.
  • Tabatabai G; Department of Neurology, Klinikum Rechts Der Isar, Technical University of Munich (TUM), Munich, Germany.
  • Hänel M; Department of Neurosurgery, Georg-August-University, Göttingen, Germany.
  • Sabel M; Department of Neurology, Nordwest-Krankenhaus Sanderbusch, Sande, Germany.
  • Gerlach R; Interdisciplinary Division of Neuro-Oncology, Departments of Neurology & Neurosurgery, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübignen, Tübingen, Germany.
  • Krex D; Department of Internal Medicine III, Klinikum Chemnitz gGmbH, Chemnitz, Germany.
  • Belka C; Department of Neurosurgery, Medizinische Fakultät, Heinrich-Heine-Universität, Düsseldorf, Germany.
  • Vatter H; Department of Neurosurgery, HELIOS Klinikum Erfurt, Erfurt, Germany.
  • Proescholdt M; Department of Neurosurgery, Technical University Dresden, Dresden, Germany.
  • Glas M; Department of Radiation Oncology, LMU Munich, Munich, Germany.
  • Herrlinger U; Department of Neurosurgery, University of Bonn Medical Center, Bonn, Germany.
J Neurooncol ; 144(3): 501-509, 2019 Sep.
Article em En | MEDLINE | ID: mdl-31325144
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Imageamento por Ressonância Magnética / Protocolos de Quimioterapia Combinada Antineoplásica / Glioblastoma Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Imageamento por Ressonância Magnética / Protocolos de Quimioterapia Combinada Antineoplásica / Glioblastoma Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article